The interaction between CD8 expansion and tumor resistance inhibition mechanisms appears to be synergistic as the AUCCD8, and AUCresistance inhibition in the triple-therapy groups (Figure 6D,F) increased beyond additivity with respect to the expectation from the two bi-therapy groups with Ag. The gene discussed is CD8A; the disease is neoplasm.